Integrated Practice Management, Medical Billing and EHR Solution for the Small Physician Practice H1N1 webVisits Now Reimbursable with P2P+ Practice Management, Medical Billing and EHR solution
Bookmark and Share

Subscribe by Email

Your email:

CollaborateMD on Facebook!

CollaborateMD on Facebook

Posts by category

The Practice Management and Medical Billing Blog

Current Articles | RSS Feed RSS Feed

H1N1 webVisits Now Reimbursable with P2P+

  | Share on Twitter Twitter | Share on Facebook Facebook | Submit to Digg digg it |  Add to delicious  delicious |  Submit to StumbleUpon StumbleUpon |  Share on LinkedIn LinkedIn |  Share On Technorati Technorati | Submit to Reddit reddit 

CollaborateMD P2P+

As H1N1 continues to get press attention in both our industry and amongst patients and peers, CollaborateMD wants to make you aware of a new reimbursable P2P+ webVisit® that will keep infected patients away from healthy patients, improve overall patient care, and even bring in revenue to providers! 

About webVisits

A webVisit consultation - powered by RelayHealth - guides patients through an interactive symptom- or condition‐based questionnaire.  These questionnaires have been authored and reviewed by academic and community‐based physicians who are experts in their fields of practice. It is a quick, convenient and effective way for patients to report their non‐urgent symptoms, such as those associated with Swine Flu, and enables physicians to deliver a fast, informed response.

Getting Started

CollaborateMD is now offering a simple configuration guide (courtesy of RelayHealth), which will walk you through the set-up of the new influenza and H1N1 webVisits for use by patients, physicians and the practice.  To request a guide, please call 888.348.8457 or drop us a line at Sales [at] CollaborateMD.com.

Who Can Use webVisits?

If you are already using one of the CollaborateMD P2P+ services listed below, we can send you the configuration guide referenced above and have you up and running in no time!  If you are interested in adding secure physician-to-patient communication to your CollaborateMD system, there are several options available to you:

  • P2P+ Option 3 (Secure Physician-to-Patient Communication)
  • P2P+ Plan 1
  • P2P+ Plan 2

We also invite you to contact us to receive our complimentary patient education literature, also courtesy of RelayHealth, which defines and explains H1N1, prevention & protection, symptoms, treatment and other pertinent information.  We look forward to helping you help the patients and providers you serve!

 

Comments

I feel this will be an asset to many providers. webVisits are a safe and secure way to efficiently treat patients. Especially with H1N1 going around. CollaborateMD is always on top of things! Way to go CMD! :)
Posted @ Tuesday, December 01, 2009 8:35 AM by Tanya Ortiz
The best treatment for influenza infections in humans is prevention by vaccination. Work by several laboratories has recently produced vaccines. The first vaccine released in early October 2009 was a nasal spray vaccine. It is approved for use in healthy individuals ages 2 through 49. This vaccine consists of a live attenuated H1N1 virus and should not be used in anyone who is pregnant or immunocompromised. The injectable vaccine, made from killed H1N1, became available in the second week of October. This vaccine is approved for use in ages 6 months to the elderly, including pregnant females. Both of these vaccines have been approved by the CDC only after they had conducted clinical trials to prove that the vaccines were safe and effective. However, caregivers should be aware of the vaccine guidelines that come with the vaccines, as occasionally, the guidelines change. Please see the sections below titled "Can novel H1N1 swine flu be prevented with a vaccine?" and the timeline update for the current information on the vaccines.
Posted @ Thursday, February 04, 2010 9:48 PM by Dentistry Roseville
a very informative website.
Posted @ Saturday, April 24, 2010 8:13 AM by mike
Post Comment
Name
 *
Email
 *
Website (optional)
Comment
 *

Allowed tags: <a> link, <b> bold, <i> italics